FilingReader Intelligence
Livzon Pharmaceutical repurchases 6.1m A shares worth RMB 4.99m
August 14, 2025 at 10:20 AM UTC•By FilingReader AI
Livzon Pharmaceutical Group has repurchased 6.1 million A shares through an extensive buyback program running from December 2024 to August 2025.
On August 14, the company bought back 125,200 A shares at prices ranging from RMB 39.64 to RMB 40.25, spending RMB 4.99 million.
The company's H shares remained unchanged at 299.8 million issued shares, while A shares outstanding stayed constant at 604.3 million excluding treasury shares.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
HKEX:1513•Hong Kong Exchange
News Alerts
Get instant email alerts when Livzon Pharmaceutical Group Inc publishes news
Free account required • Unsubscribe anytime